Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and safety of Haemocomplettan P in patients experiencing acute bleeding
2007-004612-31Phase 2Completed
- Sponsor
- CSL Limited
- Start
- Feb 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of Fibrinogen human in Bleeding and Aortic surgery, sponsored by CSL Limited. Primary endpoint: Combined number of units of allogeneic blood products. Started Feb 2008; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
BleedingAortic surgery
Beyond the preview
Go deeper on 2007-004612-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004612-31.